Dipyridamole
- Generic Name
- Dipyridamole
- Brand Names
- Aggrenox, Persantine
- Drug Type
- Small Molecule
- Chemical Formula
- C24H40N8O4
- CAS Number
- 58-32-2
- Unique Ingredient Identifier
- 64ALC7F90C
Overview
A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
Background
A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
Indication
For as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement and also used in prevention of angina.
Associated Conditions
- Coronary Artery Disease (CAD)
- Postoperative Thromboembolism
- Stroke
- Thrombosis
- Transient Ischemic Attack
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.